reported side effects of cisplatin
bone marrow depression
nephrotoxicity
ototoxicity
comprehensive list of adverse effects
way cancer medicines
body
chance
other unwanted effects
months
years after the medicine
delayed effects
certain types of cancer
leukemia
possible effects
doctor
taking
drug
side effects
medical attention
following side effects
doctor
study of patients
recommended doses of cisplatin
incurred moderate loss of renal function
months after therapy
renal dysfunction
glomerular filtration rate
gfr
effective renal plasma flow
eprf
other studies
permanent reduction in gfr
months after cisplatin therapy
elderly patients
nephrotoxicity
risk of renal toxicity
appropriate monitoring of renal function tests
aggressive hydration with chloride-containing fluids
appropriate electrolyte replacement
amifostine
thiol chemoprotectant
cisplatin nephrotoxicity
antitumor activity
renal side effects
second week after a dose of cisplatin
repeated courses of cisplatin therapy
nephrotoxicity
important dose-limiting side effect of cisplatin
patients after single doses of mg/m
renal function
baseline before subsequent doses
cisplatin-induced renal tubule damage
significant hypomagnesemia
hypokalemia
hypocalcemia
hyponatremia
hypophosphatemia
hyperuricemia
gastrointestinal side effects
nausea
vomiting
patients
nausea
vomiting
hours after treatment
days
diarrhea
hiccups
elevated serum amylase
acute cisplatin-induced emesis
hours after cisplatin administration
serotonin
appropriate antiemetics
serotonin-receptor antagonist in combination with a steroid
emesis
delayed emesis
days after cisplatin administration
oral steroid therapy
metoclopramide
prevention
delayed emesis
serotonin antagonists
limited benefits
delayed emesis
)
symptoms of the sensory polyneuropathy
toes
feet
fingers
hands in a stocking-and-glove distribution
neuropathies
prolonged therapy
months
symptoms
single dose
cisplatin neuropathies
higher dosage regimens
elderly patients
peripheral neuropathy
tinnitus
hz
hearing loss
days after initial treatment
deafness after the initial dose of cisplatin
cisplatin-induced ototoxicity
loss of outer hair cells in the cochlea
ototoxicity
high cisplatin doses
high cumulative doses
hearing impairment
hearing aids
nervous system
side effects
dose
patients
receiving cisplatin
common form of nerve damage from cisplatin
sensory polyneuropathy
other forms of nerve damage from cisplatin
autonomic neuropathies
seizures
encephalopathy
myasthenic syndrome
cortical blindness
lhermitte
sign
dorsal column myelopathy
ototoxicity
headache
loss of taste
strokes
leukoencephalopathy
reversible posterior leukoencephalopathy syndrome
rpls
myelosuppression
dose-related effect
doses
mg/m cisplatin-based therapy
significant anemia
drugs effects on other blood cells
elderly patients
myelosuppression
frequent anemia
study with patients
cycles of cisplatin in combination with other chemotherapeutic agents
patients
anemia
patients
fourth months of therapy
treatment of anemia with recombinant erythropoietin
epoetin alfa
use in the treatment of anemia in patients with nonmyeloid malignancies
anemia
result
administered chemotherapy
nadirs
circulating erythrocytes
platelets
leukocytes
days
range
most patients
day
range
leukocytes
days
most patients
day intervals
hematologic side effects
myelosuppression
cisplatin
transient myelosuppression
patients
coombs
positive hemolytic anemia
ocular side effects
optic neuritis
papilledema
cortical blindness
focal deficits
cerebral blindness
patients
receiving standard doses of cisplatin
improvement
total recovery
discontinuation of cisplatin
blurred vision
altered color perception
use of regimens with higher doses
greater dose frequencies than those
manufacturer
hypersensitivity side effects
anaphylactic-like reactions
patients
cisplatin
reactions
facial edema
wheezing
tachycardia
hypotension within a few minutes of drug administration
reactions
intravenous epinephrine
corticosteroids
antihistamines
supportive equipment
medications
possible anaphylactic-like reactions
hepatic side effects
transient elevations of liver enzymes
sgot
bilirubin
incidence
clinical importance
severity of the local tissue toxicity
concentration of the cisplatin solution
infusions of solutions with a cisplatin concentration
mg/ml
tissue inflammation
fibrosis
local side effects
soft tissue toxicity
been reported following extravasation of cisplatin
cardiovascular
side effects
myocardial infarction
cerebrovascular accident
deep vein thrombosis
pulmonary embolism
transient ischemic attack
thrombotic microangiopathy
hemolytic uremic syndrome
cerebral arteritis
blood pressure abnormalities
raynaud
phenomenon
patients
receiving bleomycin
vinblastine
cisplatin
distal ischemic changes
patients
receiving combination chemotherapy with cisplatin
gemcitabine
possible cardiotoxicity
st-t wave abnormalities
bundle branch block
atrial fibrillation
supraventricular tachycardia
bradycardia
endocrine side effects
syndrome of inappropriate antidiuretic hormone
dermatologic side effects
rash
alopecia
case of digital necrosis
metabolic side effects
chronic lipid abnormalities
black, tarry stools
blood in urine
stools
cough
hoarseness
fever
chills
dizziness
faintness
dose
heartbeat
dose
fever or chills
side pain
fever
chills
difficult urination
fever
chills
pain
redness at place of injection
red spots on skin
swelling of face
dose
unusual bleeding
bruising
wheezing
dose
joint pain
loss of balance
ringing in ears
swelling of feet
lower legs
trouble in hearing
unusual tiredness
weakness
convulsions (seizures)
loss of reflexes 
loss of taste
numbness
tingling in fingers
toes
trouble in walking 
agitation or confusion
blurred vision 
change in ability
colors
muscle cramps
sores in mouth
lips
nausea
vomiting
loss of appetite
black, tarry stools
blood in urine
stools
convulsions (seizures)
cough or hoarseness
decrease in urination
fever or chills
loss of balance
loss of reflexes
loss of taste
side pain
numbness
tingling in fingers
toes
difficult urination
red spots on skin
ringing in ears
swelling of feet
lower legs
trouble in hearing
trouble in walking
unusual bleeding
bruising